Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Bachem: Quality Control of Amino Acids and Peptides
Bachem: Quality Control of Amino Acids and Peptides. Accessed 2026-10-05.
TESTS phase 3 thymosin alpha-1 sepsis trial
Primary 2025 multicenter trial; PMID 39814420.
Thymosin alpha 1: a comprehensive review of the literature
Dominari A, et al. World J Virol. 2020. PMID 33362999.
Thymosin alpha 1 treatment for patients with sepsis
Clinical review. 2018. PMID 30063866.
Care and handling of peptides
Care and handling of peptides
Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study.
Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study.
Research news reference — pubmed.ncbi.nlm.nih.gov — news-10
Pyrogen and Endotoxins Testing: Questions and Answers
Pyrogen and Endotoxins Testing: Questions and Answers
Teaching reference — database.ich.org — ICH_Q2(R2)_Guideline_2023_1130_ErrorCorrection_2025.pdf
Sigma-Aldrich: separate enrichment and assay fields
Public reference, not NHD batch evidence.
JPT: isotope-labelled peptides
Public reference, not NHD batch evidence.
2025 thymosin alpha-1 sepsis meta-analysis
Eleven RCTs with quality and trial-sequential analyses; PMID 40969554.
PubChem Thymalfasin record
Sequence, formula, mass and synonym record; CID 16130571.
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records
